- Business Wire•5 days ago
Generex Biotechnology Corporation today announced the following access information for its investor conference call, to be hosted by Joseph Moscato, Company President & Chief Executive Officer, and his management team, tomorrow, Wednesday, February 22, 2017, at 10 am.
- Business Wire•11 days ago
Generex Biotechnology Corporation today announced that it has achieved the elimination of its outstanding derivative securities.
- Business Wire•17 days agoGenerex Provides Update on Deal to Acquire Controlling Equity Interest in Emmaus Life Sciences, Inc.
On January 23, 2017 Generex Biotechnology Corporation announced a letter of intent for the acquisition of a controlling equity interest in Emmaus Life Sciences, Inc. .
GNBT : Summary for GENEREX BIOTECHNOL COM USD0.001 - Yahoo Finance
Generex Biotechnology Corporation (GNBT)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.01 - 0.01|
|52 Week Range||0.00 - 0.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-9.97|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|